Advocacy in the USPTO - Hal Fullmer

Patent Atty, Prof at Temple & Drexel Law,
Author #1 pat pros text in law schools, one of "Best Pat. Law Books of All-Time"
Tweets are mine alone.

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

@Useful_Sciences Claim differentiation is a good reason.

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

@DanLifschitzEsq About a dozen lines:
https://t.co/OH1fnbSNGx

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

@design_law Unlearning writing rules takes time. Patent specs (not even getting to claim wording) do not get evaluated by normal writing rules -- only 112, support for claim interpretation, disclaimers, and the like.

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

https://t.co/Oo2yVijhVt

[WeAreWrestlers @WeAreWrestlers]

This is amazing! @ColeFerrell_MMA

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

Further to this question, do people develop relationships with a searcher so that the searcher can appreciate the terms of art in the technology, know the competitors, etc.?

[Prof. Dennis Crouch ⚖️ Patent Law & AI @patentlyo]

How do folks conduct pre-filing patentability searches these days?

[Aleck Ncube @aleckncube]

Happy World Intellectual Property Day @BemanyaT @_ARIPO @SuzannaJoyce @Zim_Media_Com @ChinaIPMagazine @HalFullmer @IPDZ_ @tobyschonwetter @caro_ncube @mcleansibanda @dnmlaw2011 @SMakahamadze @muzah @mwarsie @mwamuyum @CEIPIStrasbourg @WIPO @UgandaPRS @sekaikuvarika @ProsperNdlovu

[Alex Garcia 🔍 @alexgarcia_atx]

Every startup founder when they get their first customer.

(h/t arkmediauk IG)

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

And speaking of unseens, what prevents generic manuf's from making off-patent drugs to compete with those said to have new patents based on trivial changes? Is it there a regulatory reason (incl insurance issues), reluctance of MDs to prescribe anything other than the latest?

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

This Polk Wagner thread re patent evergreening is much better than the NYT Op piece.

We should want a system that promotes not only breakthrough discoveries but also step-by-step development.

[Polk Wagner @ProfPolkWagner]

So the @nytimes Editorial today is entitled "Save America's Patent System." The thrust is that the patent system is badly in need of reform. True! But the animating examples throughout the editorial are from the pharmaceutical industry. This is problematic. A thread: 🧵 1/

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

The above breezy statements about 'trivial advances' and sufficient incentives are made without evidence.

Not to be dramatic, but incorrect incentives result in drugs and procedures not developed, which would go unseen.

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

If only, ....

[International Journalism Festival @journalismfest]

@JuliaAngwin @tom_cardoso @dmehro @ASankin "In a world of big data, anecdotes just don’t prove it anymore. In the old days as journalists we could write three anecdotes and that’s a trend. And no longer we can do that.” @JuliaAngwin #ijf22

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

Hello law twitter, anybody know of a blog or other source to keep up with NIL news and analysis?

[Wrestling Changed My Life Podcast @WCMLPodcast]

Assuming NIL is here to stay, I don’t see any way the NCAA can police boosters reaching out to kids offering cash to get in the portal

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

@zoobab @sxpert1 @mkoivuka Dead for 150 years. I understand some of the arguments against patent protection for software, but isn't a flowchart/algorithm close to a working algorithm already?

[Advocacy in the USPTO - Hal Fullmer @HalFullmer]

@mkoivuka I’m not a software expert but it’s an interesting thought.